Share-based Payment Arrangement, Expense of International Stem Cell CORP from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
International Stem Cell CORP quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • International Stem Cell CORP Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $63,000, a 37% decline year-over-year.
  • International Stem Cell CORP Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $324,000, a 35% decline year-over-year.
  • International Stem Cell CORP annual Share-based Payment Arrangement, Expense for 2024 was $466,000, a 0.43% increase from 2023.
  • International Stem Cell CORP annual Share-based Payment Arrangement, Expense for 2023 was $464,000, a 16% increase from 2022.
  • International Stem Cell CORP annual Share-based Payment Arrangement, Expense for 2022 was $399,000, a 38% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

International Stem Cell CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $324,000 $63,000 -$37,000 -37% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $361,000 $61,000 -$68,000 -53% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $429,000 $100,000 -$37,000 -27% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $466,000 $100,000 -$30,000 -23% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $496,000 $100,000 -$18,000 -15% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $514,000 $129,000 +$21,000 +19% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $493,000 $137,000 +$29,000 +27% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $464,000 $130,000 +$21,000 +19% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $443,000 $118,000 +$9,000 +8.3% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $434,000 $108,000 +$18,000 +20% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $416,000 $108,000 +$17,000 +19% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $399,000 $109,000 -$11,000 -9.2% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $410,000 $109,000 -$9,000 -7.6% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $419,000 $90,000 -$82,000 -48% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $501,000 $91,000 -$143,000 -61% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $644,000 $120,000 -$144,000 -55% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $788,000 $118,000 -$155,000 -57% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $943,000 $172,000 -$152,000 -47% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $1,095,000 $234,000 -$184,000 -44% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $1,279,000 $264,000 -$234,000 -47% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $1,513,000 $273,000 -$239,000 -47% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,752,000 $324,000 -$247,000 -43% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $1,999,000 $418,000 -$88,000 -17% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $2,087,000 $498,000 -$18,000 -3.5% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $2,105,000 $512,000 +$11,000 +2.2% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $2,094,000 $571,000 +$214,000 +60% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $1,880,000 $506,000 +$199,000 +65% 01 Jan 2019 31 Mar 2019 10-Q 19 Jun 2020 2020 Q1
Q4 2018 $1,681,000 $516,000 +$142,000 +38% 01 Oct 2018 31 Dec 2018 10-K 01 Jun 2020 2019 FY
Q3 2018 $1,539,000 $501,000 +$124,000 +33% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $1,415,000 $357,000 -$22,000 -5.8% 01 Apr 2018 30 Jun 2018 10-Q 27 Aug 2019 2019 Q2
Q1 2018 $1,437,000 $307,000 +$53,000 +21% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $1,384,000 $374,000 +$87,000 +30% 01 Oct 2017 31 Dec 2017 10-K 15 Apr 2019 2018 FY
Q3 2017 $1,297,000 $377,000 +$82,000 +28% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $1,215,000 $379,000 +$92,000 +32% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $1,123,000 $254,000 +$151,000 +147% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018 2018 Q1
Q4 2016 $972,000 $287,000 +$190,000 +196% 01 Oct 2016 31 Dec 2016 10-K 09 Apr 2018 2017 FY
Q3 2016 $782,000 $295,000 +$137,000 +87% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $645,000 $287,000 +$195,000 +212% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017 2017 Q2
Q1 2016 $450,000 $103,000 -$147,000 -59% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $597,000 $97,000 -$250,000 -72% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $847,000 $158,000 -$332,000 -68% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $1,179,000 $92,000 -$282,000 -75% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $1,461,000 $250,000 -$97,000 -28% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $1,558,000 $347,000 -$56,000 -14% 01 Oct 2014 31 Dec 2014 10-Q 11 May 2015 2015 Q1
Q3 2014 $1,614,000 $490,000 +$49,000 +11% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2015 Q3
Q2 2014 $1,565,000 $374,000 -$66,000 -15% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015 2015 Q2
Q1 2014 $1,631,000 $347,000 -$62,000 -15% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 $1,693,000 $403,000 -$198,000 -33% 01 Oct 2013 31 Dec 2013 10-K 30 Mar 2015 2014 FY
Q3 2013 $1,891,000 $441,000 -$93,000 -17% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2014 Q3
Q2 2013 $1,984,000 $440,000 -$101,000 -19% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014 2014 Q2
Q1 2013 $2,085,000 $409,000 -$276,000 -40% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1
Q4 2012 $2,361,000 $601,000 01 Oct 2012 31 Dec 2012 10-K 17 Mar 2014 2013 FY
Q3 2012 $534,000 -$459,000 -46% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q2 2012 $541,000 -$358,000 -40% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $685,000 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q3 2011 $993,000 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 $899,000 01 Apr 2011 30 Jun 2011 10-Q 08 Aug 2012 2012 Q2

International Stem Cell CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $466,000 +$2,000 +0.43% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $464,000 +$65,000 +16% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $399,000 -$245,000 -38% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $644,000 -$635,000 -50% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $1,279,000 -$808,000 -39% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $2,087,000 +$406,000 +24% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $1,681,000 +$297,000 +21% 01 Jan 2018 31 Dec 2018 10-K 01 Jun 2020 2019 FY
2017 $1,384,000 +$412,000 +42% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019 2018 FY
2016 $972,000 +$375,000 +63% 01 Jan 2016 31 Dec 2016 10-K 09 Apr 2018 2017 FY
2015 $597,000 -$821,000 -58% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
2014 $1,418,000 -$275,000 -16% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $1,693,000 -$668,000 -28% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015 2014 FY
2012 $2,361,000 -$1,179,000 -33% 01 Jan 2012 31 Dec 2012 10-K 17 Mar 2014 2013 FY
2011 $3,540,000 01 Jan 2011 31 Dec 2011 10-K 26 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.